查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球股骨幹骨折市場
市場調查報告書
商品編碼
1140737

2022-2029 年全球股骨幹骨折市場

Global Femur Shaft Fracture Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

交通事故增加推動市場增長

汽車和摩托車碰撞是股骨幹骨折最常見的原因。開車時被車輛撞到也是常見的原因。這些交通事故導致高能碰撞和股骨骨折，從而推動市場增長。根據世界衛生組織的數據，到 2021 年，將有大約 130 萬人死於道路交通事故。另有 20-5000 萬人遭受非致命傷害，其中許多人因受傷而致殘。此類病例的增加對股骨幹骨折的治療產生了很高的需求，並促進了市場增長。世界上大約 93% 的道路死亡事故發生在新興國家，儘管世界上大約 60% 的汽車車隊都在這些國家。道路交通傷害是 5-29 歲兒童和青少年死亡的主要原因。每年約有 130 萬人死於交通事故。

此外，研究活動的增加以及使用髓內釘進行股骨幹治療的發展推動了預測期內的市場增長。此外，越來越多的老年人出現易骨折的骨骼虛弱，這可能導致股骨幹骨折病例增加。

然而，股骨幹骨折需要手術治療，作為一種臨時治療方法，將金屬針和螺釘植入骨內，嚴重時通常進行髓內釘。這些手術的高成本是製約市場增長的一個因素。

地理滲透

預計北美地區將主導全球股骨幹骨折市場

該研究按地區分析了全球市場的股骨幹骨折市場，包括北美、歐洲、亞太地區、南美、中東和非洲。

北美在 2021 年將主導全球股骨幹骨折市場。預計美國在預測期內將代表北美的大幅增長。由於已建立的醫療保健基礎設施和高人均醫療保健費用，預計美國的股骨幹骨折將增加。

預計亞太地區在預測期內的價值也將出現顯著增長。預計交通事故的增加將推動該地區的市場增長。預計亞太地區股骨幹骨折市場在預測期內將出現快速增長。這是為了促進該地區的市場增長，因為該地區的老年人口增加，老年人的弱骨很容易骨折。此外，中國和印度人口規模的增加、骨科疾病的增加以及經濟增長也有望推動亞太地區股骨幹骨折市場的增長。

競爭格局。

為全球市場增長做出貢獻的主要股骨幹骨折參與者包括 Stryker、B. Braun Melsungen AG、Zimmer Biomet、Smith & Johnson、Orthopedic Implants、Orthofix Holdings、Right Medical Group NV、Advanced Ortheopathic Solutions、Eisam Ortobedi 和 Tivi Sihazra .領先公司正在為全球股骨幹骨折市場的增長採用新產品發布和擴張戰略。2022 年 9 月，Stryker 推出了新的 Gamma4 髖部骨折釘系統。這種新的 Gamma 系統為外科醫生提供了 Stryker 的下一代髓內釘系統。該系統適用於治療穩定性和不穩定性骨折、骨穩定和矯正頭部、轉子、轉子下和股骨幹的骨畸形。該系統具有不同的功能，例如可將刮削機率降低 66% 的精密銷。2022 年 3 月，B.Brown 收購了透析濃縮液製備專家 Intermet Medicine & Technique。此次收購完善了 B.Braun Avitum 部門作為體外血液治療（透析）系統供應商的廣泛產品組合。2021 年 9 月，B.Braun Melsungen AG 完成了對 Sterinova Inc. 的收購。Sterinova 將繼續作為 B.Braun 的子公司運營。此次收購是公司發展的有力支持者，並推動了 Smith+Nephew 機器人和 Real Intelligence 戰略。

COVID-19 的影響。它對全球股骨幹骨折市場產生負面影響。

在 COVID-19 爆發期間，股骨幹骨折減少。與 2019 年股骨幹骨折數據相比，股骨幹骨折病例減少了 28.4%。醫院已經註意到骨折病例和手術的減少。由於封鎖，交通事故案件因股骨幹骨折減少而減少。交通限制和學校、企業和工廠等許多商業活動的關閉限制了居民的活動，減少了股骨幹骨折病例的數量。

全球股骨幹骨折市場報告提供了大約 53 個市場數據表、40 個數字和 170 頁的結構。

目錄

第一章 調查方法和範圍

  • 調查方法
  • 調查目的和範圍

第二章市場定義和概述

第三章執行摘要

  • 按類型劃分的市場細分
  • 最終用戶的市場細分
  • 區域市場細分

第四章市場動態

  • 市場影響因素
    • 促進者
      • 交通事故數量增加
      • 激活研發
    • 抑製劑
      • 飆升的治療費用
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST分析
  • 定價分析
  • 監管分析
  • 保險報銷分析
  • 未滿足的需求
  • 專利趨勢

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 中的價格動態
  • 供需譜
  • 大流行期間與市場相關的政府努力
  • 製造商的戰略舉措
  • 概括

第 7 章 按類型

  • 1型骨折
  • 2型骨折

第 8 章最終用戶

  • 醫院
  • 專科診所和骨科診所

第9章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東/非洲

第 10 章 競爭格局

  • 競爭情景
  • 市場/份額分析
  • 併購分析

第十一章公司簡介

  • Stryker
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務概覽
  • B. Braun Melsungen AG.
  • Zimmer Biomet.
  • Smith+Nephew.
  • Johnson & Johnson.
  • Orthopaedic Implant Company.
  • ORTHOFIX HOLDINGS, INC
  • WRIGHT MEDICAL GROUP N.V.
  • ADVANCED ORTHOPAEDIC SOLUTIONS
  • Aysam Ortopedi & Tibbi Cihazlar（*LIST NOT EXHAUSTIVE）

第 12 章 重要注意事項

第 13 章 數據管理

簡介目錄
Product Code: DMMD3136

Market Overview

Femur Shaft Fracture Market was valued at USD YY million in 2021. It is forecasted to reach USD YY million by 2029, growing at a CAGR of YY % during the forecast period (2022-2029).

A femur shaft fracture is a break along the length of the leg bone. Based on the force that causes the split, femur breaks differ tremendously. Bone parts will line up properly (stable fracture) or be out of alignment (displaced fracture). The skin can be intact around the fracture (closed fracture), or the skin can be punctured by the bone (open fracture). Typically, a fracturing of the femoral shaft produces acute, intense pain. The wounded leg would not be able to place weight on it, and it will appear deformed, thinner and no longer straight than the other leg. The major factors propelling the Femur shaft fracture market growth are the rising incidents of high-energy collisions, mainly road accidents falling from high altitudes, gunshots and more. The increasing prevalence of these incidents causes femur shaft fractures driving the market growth.

Market Dynamics: Increasing incidences of road accidents drives the market growth

A motor vehicle or motorcycle crash is the most prominent cause of femoral shaft fracturing. Another common cause is being struck by a vehicle while driving. These road accidents result in high-energy collisions, which break the femur bone driving the market growth. According to World Health Organization, in 2021, approximately 1.3 million people will be cut short due to a road traffic crash. Around 20 to 50 million more peoples suffer non-fatal injuries, with many incurring a disability due to their injury. This increase in cases creates a higher demand for femur shaft fracture treatment driving the market growth. Around 93% of the world's road fatalities occur in developing countries, even though these countries have approximately 60% of the world's vehicles. Road traffic injuries are a major cause of death for children and young adults aged 5-29 years. Approximately 1.3 million people die each year from road traffic crashes.

Also, increasing research activities along with the evolution of the use of intramedullary nails for treating the femur shaft market accelerates the market growth during the forecast period. Moreover, the rising geriatric population can lead to increasing cases of femur shaft fracture as the older population experiences weakness in bones which can easily be fractured.

However, the femur shaft fractures require surgery to heal, which uses metal pins, and screws being placed into the bone as a temporary treatment, while intramedullary nailing is used for severe cases. The cost for these surgeries is higher, which restricts the market growth.

Market Segmentation: The type 2 fracture segment is projected to be the dominant segment in the market during the forecast period.

Based on the type, the femur shaft fracture market has been classified into type 1 fracture and type 2 fractures.

Type 2 fracture dominated the global market in 2019, whereas Type 1 Fracture is expected to present considerable growth in the near future. Type 2 is a large butterfly of less than 50% of the bony width with greater than 50% of cortex intact. The severe accident mostly leads to Type 2 fracture owing to the higher energy collision which propels the segmental growth in the forecast period.

Femur shaft fracture is segmented based on End User, which includes Hospitals, Specialty/Orthopedic Clinics. Hospitals segment held significant market share in forecast period.

Most of the accidental cases are brought directly into the hospitals for treatment, supporting the segment growth during the forecast period. Moreover, the Specialty/Orthopedic Clinics is expected to project a considerable CAGR during the forecast period.

Geographical Penetration: North America region is expected to dominate the global femur shaft fracture market

Based on geography, the study analyzes the Femur Shaft Fracture market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America is holding a dominant position in the global Femur shaft fracture market in 2021. The U.S. is expected to represent considerable growth in North America during the forecast period. In the U.S., the femur shaft fracture is expected to grow owing to the Well-established healthcare infrastructure and high healthcare expenditure per capita.

Moreover, Asia Pacific is expected to represent significant growth in terms of value during the forecast period. Increasing road accidents are expected to propel market growth across the region. The femur shaft fracture market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the increasing geriatric population in the region, as the weak bones of the older population can easily be fractured, driving the market growth in the region. Also, a large population base, an increase in the incidence of orthopedic diseases, and economic growth in China, and India, are expected to augment the growth of the Asia Pacific femur shaft fracture market.

Competitive Landscape:

The key femur shaft fracture players which are contributing to the growth of the global market include Stryker, B. Braun Melsungen AG., Zimmer Biomet., Smith+Nephew., Johnson & Johnson., Orthopaedic Implant Company, Orthofix Holdings, Inc, Wright Medical Group N.V., Advanced Orthopaedic Solutions, Aysam Ortopedi & Tibbi Cihazlar, among others. The major players are adopting new product launches and expansion strategies for global growth in the femur shaft fracture market. In September 2022, Stryker launched New Gamma4 Hip Fracture Nailing System. This new Gamma System provided surgeons with the next generation of Stryker's intramedullary nailing system. This system is indicated for the treatment of stable and unstable fractures as well as for the stabilization of bones and correction of bone deformities in the intracapsular, trochanteric, subtrochanteric and shaft regions of the femur. This system has different features like precision pin, which reduce the potential of skiving by 66%. In March 2022, B.Braun acquired Intermedt Medizin & Technik GmbH, a specialist in preparing dialysis concentrates. Through this acquisition, the company completed the extensive product portfolio of its B. Braun Avitum division as a systems provider for extracorporeal blood treatment (dialysis). In September 2021, B.Braun Melsungen AG completed the acquisition of Sterinova Inc. Furthermore, Sterinova continues to operate as a subsidiary of B.Braun. In January 2022, Smith+Nephew, the global medical technology business, acquired Engage Surgical, owner of the only cementless unicompartmental (partial) knee system commercially available in the U.S. This acquisition strongly supports companies for growth and drove Smith+Nephew Robotics and Real Intelligence strategy.

COVID-19 Impact: Negative impact on the global femur shaft fracture market.

During the outbreak of COVID-19, there was a decrease in fractures in the femur shaft fracture. Compared to the 2019 femur shaft fracture data, there was a decrease in femur shaft fracture cases by 28.4%. The hospitals noticed a reduction in fracture cases and surgeries. Due to the lockdown, road accident cases are decreased due to reduced femur shaft fracture. With traffic restrictions and the closure of many commercial activities, a school, companies and factories have surely limited the movement of the population owing to a reduction in femur shaft fracture cases.

The global femur shaft fracture market report would provide an access to approximately 53 market data tables, 40 figures and 170 pages

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by End User
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing incidences of Road Accidents
      • 4.1.1.2. Increasing Research and development activities
    • 4.1.2. Restraints:
      • 4.1.2.1. High Cost of Treatment
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
  • 7.3. Market Attractiveness Index, By Type Segment
    • 7.3.1. Type 1 Fracture*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Type 2 Fracture

8. By End User

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
  • 8.3. Market Attractiveness Index, By End User Segment
    • 8.3.1. Hospitals*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Specialty/Orthopedic Clinics

9. By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. U.S.
      • 9.4.5.2. Canada
      • 9.4.5.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. Germany
      • 9.5.5.2. U.K.
      • 9.5.5.3. France
      • 9.5.5.4. Italy
      • 9.5.5.5. Spain
      • 9.5.5.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.5.1. Brazil
      • 9.6.5.2. Argentina
      • 9.6.5.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.5.1. China
      • 9.7.5.2. India
      • 9.7.5.3. Japan
      • 9.7.5.4. Australia
      • 9.7.5.5. Rest of Asia Pacific
  • 9.8. Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Stryker*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. B. Braun Melsungen AG.
  • 11.3. Zimmer Biomet.
  • 11.4. Smith+Nephew.
  • 11.5. Johnson & Johnson.
  • 11.6. Orthopaedic Implant Company.
  • 11.7. ORTHOFIX HOLDINGS, INC
  • 11.8. WRIGHT MEDICAL GROUP N.V.
  • 11.9. ADVANCED ORTHOPAEDIC SOLUTIONS
  • 11.10. Aysam Ortopedi & Tibbi Cihazlar (*LIST NOT EXHAUSTIVE)

12. Premium Insights

13. DataM Intelligence Analysis

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us